Glucagon

🧮 Dose calculator

Severe hypoglycaemia · Regimen source: FDA Gvoke (glucagon) · 2.1

• • ≥12 y: 1 mg. 2 to <12 y: <45 kg → 0.5 mg; ≥45 kg → 1 mg. If no response after 15 min, one more dose from a new device. FDA Gvoke (glucagon) · 2.1

Enter age and weight.

👥 Special populations

• 🤰 PregnancyUse with caution

  Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Gvoke (glucagon) · 8.1

  “Risk Summary Available data from case reports and a small number of observational studies with glucagon use in pregnant women over decades of use have not identified a drug-associated risk of major birth defects, miscarriage or adverse maternal or fetal outcomes.”

• 🤱 BreastfeedingUse with caution

  Label: use with caution while breastfeeding; see the label text. FDA Gvoke (glucagon) · 8.2

  “Risk Summary There is no information available on the presence of glucagon in human or animal milk, the effects of the drug on the breastfed infant, or the effects of the drug on milk production.”

• 👶 ChildrenUse with caution

  The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Gvoke (glucagon) · 8.4

  “The safety and effectiveness of GVOKE for subcutaneous use for the treatment of severe hypoglycemia in patients with diabetes have been established in pediatric patients aged 2 years and older.”

• 👴 Older adultsUse with caution

  Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Gvoke (glucagon) · 8.5

  “Clinical studies of GVOKE and GVOKE VialDx did not include sufficient numbers of patients aged 65 and over to determine whether they respond differently from younger adult patients.”

• ⚥ Females & males of reproductive potentialNo data

  The source for this drug has no section for this group.